Catalyst Biosciences, Inc. (CBIO) financial statements (2020 and earlier)

Company profile

Business Address 611 GATEWAY BLVD., SUITE 710
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:7712032173310792
Cash and cash equivalents15311410295654
Short-term investments618918735138
Other undisclosed cash, cash equivalents, and short-term investments0(0)(0)00  
Restricted cash and investments 051934  
Receivables15 00000
Prepaid expense     11
Deposits current assets    0  
Other undisclosed current assets44112  
Total current assets:9612439386910894
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment0000101
Long-term investments and receivables     351
Long-term investments     351
Intangible assets, net (including goodwill)      0
Intangible assets, net (excluding goodwill)      0
Deposits noncurrent assets  0    
Restricted cash and investments   00  
Other noncurrent assets01   00
Total noncurrent assets:21011452
TOTAL ASSETS:99125403870112146
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities135322310
Accounts payable4111101
Accrued liabilities7211139
Employee-related liabilities21111  
Deferred revenue15
Debt0 51934 1
Deferred rent credit 0
Derivative instruments and hedges, liabilities    1  
Deferred revenue and credits000  
Total current liabilities:29592238311
Noncurrent Liabilities
Long-term debt and lease obligation1     0
Long-term debt, excluding current maturities      0
Operating lease, liability1
Liabilities, other than long-term debt 0 00  
Deferred revenue and credits 00  
Deferred rent credit 0
Total noncurrent liabilities:10 00 0
Total liabilities:30592238311
Stockholders' equity
Stockholders' equity attributable to parent68120311631109135
Common stock0000000
Additional paid in capital327323204164162422415
Accumulated other comprehensive income (loss)0(0) (0)000
Accumulated deficit(259)(203)(173)(148)(131)(313)(281)
Total stockholders' equity:68120311631109135
TOTAL LIABILITIES AND EQUITY:99125403870112146

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenue, net10204
Gross profit: 010204
Operating expenses(57)(34)(23)(21)(16)(30)(51)
Operating loss:(57)(34)(22)(20)(14)(30)(47)
Nonoperating income (expense)(0)200 11
Investment income, nonoperating 0   11
Other nonoperating income (expense)(0)200   
Interest and debt expense   0(1)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes     00
Loss from continuing operations before income taxes:(57)(32)(22)(20)(15)(29)(47)
Income tax expense     (3)(0)
Loss before gain (loss) on sale of properties:(57)(32)(22)(20)(15)(33)(47)
Other undisclosed net income22     
Net loss:(55)(30)(22)(20)(15)(33)(47)
Other undisclosed net income attributable to parent   31  
Net loss attributable to parent:(55)(30)(22)(17)(15)(33)(47)
Preferred stock dividends and other adjustments  (4)    
Net loss available to common stockholders, diluted:(55)(30)(26)(17)(15)(33)(47)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(55)(30)(22)(20)(15)(33)(47)
Other comprehensive loss     (0) 
Comprehensive loss:(55)(30)(22)(20)(15)(33)(47)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)0310(0)
Comprehensive loss, net of tax, attributable to parent:(55)(30)(22)(17)(15)(33)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: